MARTINSRIED, GERMANY and MUNICH, GERMANY–(Marketwire – Feb 8, 2013) – MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced that the
US Patent and Trademark Office (USPTO) has granted the first patent
covering the
Company’s latest antibody platform Ylanthia, which became commercially
available
for existing and new partners in 2012.

Source: http://www.marketwire.com/mw/release.do?id=1754590&sourceType=3

This entry was posted on Friday, February 8th, 2013 at 1:43 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.